NCT07273760Completed
VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation
A Prospective and Observational Study for Effectiveness and Safety Evaluation of VedAryo® (Vedolizumab) in Patients With Inflammatory Bowel Disease
Source: ClinicalTrials.gov · Last updated 10 Dec 2025
Brief summary (registry, in English)
The aim of this observational study is to evaluate Effectiveness and safety of VedAryo® (Vedolizumab) in male or female participants with clinical diagnosis of Inflammatory Bowel Disease. The main questions are aim to answer: 1. Is VedAryo® (Vedolizumab) effective in the treatment of Inflammatory Bowel Disease? 2. Is VedAryo® (Vedolizumab) safe in the treatment of Inflammatory Bowel Disease? In this study, there is no comparison group. Participants received VedAryo® (Vedolizumab)
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 150 (actual)
- First submitted
- 25 Nov 2025
- Start date
- 16 Jul 2023
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- AryoGen Pharmed Co.
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07273760
What you commit to
- Study type: Observational
- Participants enrolled: 150
- From 16 Jul 2023 to the primary completion date, 30 Sept 2025
- 12 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients diagnosed with Inflammatory bowel disease, including Ulcerative Colitis and Crohn's disease
- Patients with an indication of vedolizumab therapy
- Ability to comprehend and willingness to sign the informed consent form for this study.
Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dr. Ali Beheshti-Namdar Clinic Coordinator of this site? Confirm its status | Mashhad | Iran | Unknown status |
| Dr. Hassan Vossoughinia Clinic Coordinator of this site? Confirm its status | Mashhad | Iran | Unknown status |
| Gilan Gastroenterology and Hepatology Subspecialty Clinic Coordinator of this site? Confirm its status | Rasht | Iran | Unknown status |
| Dr. Mohammad-Javad Kaviani Clinic Coordinator of this site? Confirm its status | Shiraz | Iran | Unknown status |
| Shariati Hospital Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
| Dr. Mahtab Shabani Clinic Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
| Professor Shahram Agah Gastroenterology, Hepatology, and Endoscopy Subspecialty Clinic Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
| Mehr Specialty Clinic Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
| Dr. Hamid Asadzadeh Aghdaei Clinic Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
| Dr. Naser Ebrahimi Daryani Clinic Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
| Taleghani Hospital Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
| Imam Khomeini Hospital Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.